September 14, 2015
A Pennsylvania federal judge on Friday suspended a false advertising suit by GlaxoSmithKline LLC against Teva Pharmaceuticals USA Inc. over Teva's marketing of its generic Wellbutrin as equivalent to the brand-name drug, though another similar suit is going forward.
May 15, 2015
GlaxoSmithKline LLC on Thursday filed a second lawsuit in Pennsylvania federal court against Teva Pharmaceuticals USA Inc. over a generic version of Wellbutrin XL, this time alleging Teva's false advertising that its generic was comparable to the antidepressant cost GSK's business partner millions.